Graves Orbitopathy Clinical Trials

16 clinical trials for Graves Orbitopathy across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED) — RECRUITING · PHASE3
• Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease — RECRUITING · PHASE2
• Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) — RECRUITING · PHASE2
• Mycophenolate sodium in Graves’ orbitopathy — COMPLETED · PHASE2
• Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease — NOT_YET_RECRUITING · PHASE1
• A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED) — TERMINATED · PHASE3
• Development of a Non-Invasive Prognostic Test for Graves Orbitopathy — ACTIVE_NOT_RECRUITING · NA
• A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease — COMPLETED · PHASE2
• The use of [68Ga]Ga-FAPI PET/MRI in assessing disease activity in patients with Graves’ orbitopathy — NOT_YET_RECRUITING · PHASE2
• A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) — ACTIVE_NOT_RECRUITING · PHASE2
• Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study — COMPLETED · PHASE3
• Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease — OTHER
• A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy — OTHER · PHASE3
• A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study — NOT_YET_RECRUITING · PHASE3
• Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy — OTHER · NA
• Immunological Follow-up of Patients With Basedow's Orbitopathy — COMPLETED

Refine this search